Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer.

MLA

Munhoz, Rodrigo R., et al. “Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer.” JAMA Oncology, vol. 2, no. 1, Jan. 2016, pp. 65–73. EBSCOhost, https://doi.org/10.1001/jamaoncol.2015.3251.

APA

Munhoz, R. R., Pereira, A. A. L., Sasse, A. D., Hoff, P. M., Traina, T. A., Hudis, C. A., & Marques, R. J. (2016). Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer. JAMA Oncology, 2(1), 65–73. https://doi.org/10.1001/jamaoncol.2015.3251

Chicago

Munhoz, Rodrigo R., Allan A. L. Pereira, André D. Sasse, Paulo M. Hoff, Tiffany A. Traina, Clifford A. Hudis, and Ricardo J. Marques. 2016. “Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer.” JAMA Oncology 2 (1): 65–73. doi:10.1001/jamaoncol.2015.3251.